Latest H5N1 clinical trials Stories
QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Ms.
-The Company launches the clinical development of its seasonal flu vaccine- QUEBEC CITY, Feb. 8 /PRNewswire-FirstCall/ - Medicago Inc.
The World Health Organization (WHO) is reviewing the safety of GlaxoSmithKline's Pandemrix H1N1 flu vaccine after a Finnish study suggested children who got the shot were nine times more likely to suffer from narcolepsy.
- Company's results continue to be amongst the best for influenza vaccine manufacturing technologies - -Company's VLP induced the production of antibodies that cross react with multiple strains of influenza- QUEBEC CITY, Feb. 1 /PRNewswire-FirstCall/ - Medicago Inc.
PRINCETON, N.J., Jan. 27, 2011 /PRNewswire/ -- Soligenix, Inc.
The Phase 2a clinical trial for HIV/AIDS vaccine has now expanded from 225 to 300 participants (Vocus/PRWEB) January 13, 2011 GeoVax Labs, Inc. recently announced the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products.
Two doses of the chickenpox vaccine provide excellent protection in children against the highly-contagious itchy disease, according to a new study.
Two doses of the varicella, or chickenpox, vaccine provide excellent protection in children against this highly contagious and, in some cases, severe disease.
BEIJING, Dec. 28, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
QUEBEC CITY, QC, Dec. 22 /PRNewswire/ - Medicago Inc.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.